Search Results
Results found for "fibrotic diseases"
- 📰 GPCR Weekly News, August 21 to 27, 2023
Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
- 📰 GPCR Weekly News, August 14 to 20, 2023
Classified GPCR News from August 14 to 20, 2023 Adhesion GPCRs Amelioration of non-alcoholic fatty liver disease
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
In Adenosine Receptors in Health and Disease; Wilson, C. N., Mustafa, S.
- 📰 GPCR Weekly News, February 5 to 11, 2024
G-protein coupled receptor-mediated vasocontraction in rat coronary arteries GPCRs involved in metabolic diseases
- From Failed Experiments to Predictive GPCR Models
One of his early projects involved the A2A adenosine receptor, a GPCR with known relevance in diseases
- 📰 GPCR Weekly News, August 28 to September 3, 2023
A case for (mutant) G protein-coupled receptors Reviews, GPCRs, and more RGS2 and female common diseases
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
The implications extend to neurodegeneration, metabolic disease, and regenerative pharmacology—fields
- 📰 GPCR Weekly News, January 8 to 14, 2024
more The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- 📰 GPCR Weekly News, January 1 to 7, 2024
midgut development in Drosophila Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases
- GPCR Buzz of the Week | Sep 23 - 29, 2024
and design of 5-HT6 antagonists through assessment of ANN-QSAR models in the context of Alzheimer's disease
- 📰 GPCR Weekly News, March 20 to 26, 2023
Endocrinology, and Taste Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease
- 📰 GPCR Weekly News, April 10 to 16, 2023
Adhesion GPCRs Downstream signaling of the disease associated mutations on GPR56/ADGRG1.
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
steatosis and obesity GPCRs in Neuroscience GNG5 is a novel regulator of Aβ42 production in Alzheimer's disease
- 📰 GPCR Weekly News, June 17 to 23, 2024
grandiflora against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease
- 📰 GPCR Weekly News, January 22 to 28, 2024
Financial Results Novartis Automates New Radioligand Therapy Production Plant Novartis’ Lutathera reduces disease
- 📰 GPCR Weekly News, May 13 to 19, 2024
GPCR-related genes analysis Reviews, GPCRs, and more GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
GPCR-Mediated Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Disease
- 📰 GPCR Weekly News, December 18 to 31, 2023
optogenetically functionalized Drosophila dopamine receptors Targeting CB2R in astrocytes for Parkinson's disease
- 📰 GPCR Weekly News, March 13 to 19, 2023
and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases
- 📰 GPCR Weekly News, February 19 to 25, 2024
A Perspective on Class C GPCR Based Genetically Encoded Biosensors Emergence of lumpy skin disease virus
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
several inflammatory pathologies , including asthma, arthritis, sepsis, and more recently, Alzheimer's disease
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Endocrinology, and Taste The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
It is involved in several pathophysiological processes such as Parkinson’s disease, depression, addiction Cannabinoid Receptor Type 1 in Parkinson’s Disease: A Positron Emission Tomography Study with [ 18 F
- 📰 GPCR Weekly News
Ghrelin receptor signaling in health and disease: a biased view.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards
- Odorant receptors – a bit of smell for drug discovery
to the diversity of the OR family it will be critical to select potential targets to modulate in a disease
- Decoding β-Arrestins: from Structure to function
the promise of unveiling novel insights into cellular signaling and its implications for health and disease
- Structural landscape of the Chemokine Receptor system
will pave the way for significant advancements in the development of therapeutics for a wide range of diseases









